Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
The Journal of Rheumatology
|
October 23, 1997
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group
M Tuttleman, S R Pillemer, B C Tilley, et al.
Arthritis and Rheumatism
|
March 1, 1997
Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis
S R Pillemer, S E Fowler, B C Tilley, et al.
Annals of Neurology
|
June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
J Broderick, M Lu, C Jackson, et al.
Neurology
|
May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group
S C Fagan, L B Morgenstern, A Petitta, et al.
Neurology
|
December 13, 2000
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study
J R Marler, B C Tilley, M Lu, et al.
Obstetrics and Gynecology
|
April 1, 1978
Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project
D Labarthe, E Adam, K L Noller, et al.
Annals of Internal Medicine
|
January 15, 1995
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group
B C Tilley, G S Alarcón, S P Heyse, et al.
JAMA
|
December 12, 2001
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke
S C Patel, S R Levine, B C Tilley, et al.
The Journal of Rheumatology
|
July 1, 1997
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial
G B Bluhm, J T Sharp, B C Tilley, et al.
Stroke
|
August 6, 1999
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy
J C Grotta, D Chiu, M Lu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
The Journal of Rheumatology
|
October 23, 1997
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group
M Tuttleman, S R Pillemer, B C Tilley, et al.
Arthritis and Rheumatism
|
March 1, 1997
Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis
S R Pillemer, S E Fowler, B C Tilley, et al.
Annals of Neurology
|
June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
J Broderick, M Lu, C Jackson, et al.
Neurology
|
May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group
S C Fagan, L B Morgenstern, A Petitta, et al.
Neurology
|
December 13, 2000
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study
J R Marler, B C Tilley, M Lu, et al.
Obstetrics and Gynecology
|
April 1, 1978
Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project
D Labarthe, E Adam, K L Noller, et al.
Annals of Internal Medicine
|
January 15, 1995
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group
B C Tilley, G S Alarcón, S P Heyse, et al.
JAMA
|
December 12, 2001
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke
S C Patel, S R Levine, B C Tilley, et al.
The Journal of Rheumatology
|
July 1, 1997
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial
G B Bluhm, J T Sharp, B C Tilley, et al.
Stroke
|
August 6, 1999
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy
J C Grotta, D Chiu, M Lu, et al.
Page
of 7